English (international)
Eesti
Български
Deutsch
Français
Español (Latinoamérica)
Polski
Magyar
Română
Smith & Nephew PLC
Closed
1,196.5 1.4
Overview
Share price change
24h
Min
1194.5
Max
1198.5
Income | 107M |
|---|---|
Sales | 12M 2.8B |
P/E Sector Avg | 26.67 41.445 |
EPS | 0.376 |
Profit margin | 3.785 |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +12.34 upside |
Next Dividend date | 8 Nov 2024 |
|---|---|
Next Ex Dividend date | 3 Oct 2024 |
Market Cap | -72M 10B |
|---|---|
Previous open | 1195.1 |
Previous close | 1196.5 |
Smith & Nephew PLC Chart
Related News
Smith & Nephew PLC Forecast
Price Target
By TipRanks
12.34% upside
12 Months Forecast
Average 1,346.44 GBX 12.34%
High 1,500 GBX
Low 1,145 GBX
Based on 9 Wall Street analysts offering 12 month price targets forSmith & Nephew PLC - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Sales
Cost of sales
Gross profit on sales
EBITDA
Operating profit
$
About Smith & Nephew PLC
Smith & Nephew plc is a global medical devices business operating in the markets for advanced surgical devices, which includes orthopedic reconstruction, trauma and sports medicine and advanced wound management. The Company operates in two segments: Advanced Surgical Devices and Advanced Wound Management. The Companys Advanced Surgical Devices (ASD) segment offers products and technologies, which include orthopedic reconstruction, trauma and extremities, sports medicine joint repair, arthroscopy enabling technologies and other advanced surgical devices (ASD). The Companys Advanced Wound Management (AWM) segment offers products, including Advanced Wound Care, Advanced Wound Devices and Advanced Wound Bioactives. The Company operates across the world and has distribution channels in over 100 countries.